January/February 2022 • PharmaTimes Magazine • 4-5
Contents
Features
Including diversity in clinical trials
Naked Eye is focused on incorporating
justice into the patient experience
Analysis
Oli Hudson examines the factors likely to have the biggest impact in 2022
Angela McFarlane interprets the survey results
Are regenerative peptides the answer to current treatment challenges?
SmartPeople
13.
Smart People: Martin Lush
Interview with Martin Lush, global VP, health sciences, Europe, at NSF International
28.
2020 winners of the Marketer, Communications and Sales Awards
Celebrating the top pharma marketers, communicators and salespeople
34.
Patient Files: pulmonary fibrosis
Carol Fielding explains her diagnosis
37.
Appointments